Efficacy and Safety of Multi-Instillations of Apaziquone in Patients With Non-Muscle Invasive Bladder Cancer
Clinical trial NCT01410565 · TERMINATED
Trial details
- NCT number
- NCT01410565
- Sponsor
- Spectrum Pharmaceuticals, Inc
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-07-01
- Primary completion
- 2014-03-01
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.